Article metrics

other Versions

PDF
Randomised controlled trial
Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes

Statistics from Altmetric.com

Online download statistics by month:

AbstractFullPDF
Mar 201718217035
Apr 20173919642
May 20173015836
Jun 2017498316
Jul 2017694316
Aug 2017773818
Total446688163